Randox calls upon NI engineers to build COVID-19 testing platforms

Home - Testing - Page 2

Randox calls upon NI engineers to build COVID-19 testing platforms

randox-careers

About Us       News        Contact

05 April 2020

COVID-19 Engineering Recruitment Drive

 

RANDOX CALLS UPON NI ENGINEERS TO BUILD COVID-19 TESTING PLATFORMS

Randox Laboratories has today announced it is recruiting 160 mechanical, electrical and manufacturing engineers to enhance its capacity for COVID-19 testing.

 The engineers, who are due to begin work at the Randox Science Park from the middle of May, will be involved in the fast-tracked development of specialist molecular analysers used to detect the presence of COVID-19.

These testing platforms will be used to further enhance the government’s national testing scheme for key workers, as well as to facilitate testing more broadly across the general populace.

Dr Peter FitzGerald, Managing Director of Randox Laboratories, commented;

“It is Randox’s priority to ensure that we support the UK’s effort to fight COVID-19, by testing at scale. We know that this is the most effective way to both save lives and promote a timely return to a more normal society.

“We continue to ramp up our COVID-19 testing capabilities – not only by increasing our production of testing kits, but also by accelerating the build schedule for the testing analysers on which the tests are performed.

“We are aiming, by working at maximum efficiency in a greatly accelerated time frame of 6-7 weeks, to manufacture 200 of our most state-of-the-art testing platforms, which will greatly enhance our testing capacity at Randox.”

Randox has, in recent weeks, established a number of new teams responsible for the development, manufacturing and distribution of COVID-19 testing kits for the national testing programme.

The company is also interested in speaking to anyone with experience in mechanical, electrical or manufacturing engineering. Invest Northern Ireland is helping by contacting companies which may be able to temporarily release resources to help meet this urgent staffing requirement.

Dr FitzGerald added;

“To meet the unprecedented demand for COVID-19 testing, we have been redeploying our own personnel to various COVID-19 critical departments, but are now also recruiting for a number of specialist disciplines.

“Everyone at Randox has a vital role to play in the practical application of COVID-19 testing, and for engineers in particular, this is a unique opportunity to make a positive impact in the fight against COVID-19, by directly contributing in no small part to the national testing programme.”

Anyone interested in the Randox COVID-19 Engineering Drive should apply at careers.randox.com

Want to know more?

Contact us or visit our Randox Careers

Find out more about Randox Careers

Careers News

Vacancies

Our People

Careers Website


RTS Blog | Wales introduce minimum alcohol pricing

12 March 2020

Wales introduce minimum alcohol pricing

 

RTS Blog | Wales introduce minimum alcohol pricing

From 2nd March, there was a change in the way alcohol is sold in Wales, with the introduction of minimum unit pricing (MUP).

Retailers and any outlets serving alcohol must charge at least 50p a unit, meaning a typical bottle of wine costs no less than £4.69. Welsh Health Minister Vaughan Gething said it would tackle “harmful and damaging” drinking of cheap, strong alcohol.

A recent report found that alcohol sales in Scotland had dropped after a similar system was implemented in May 2018. The Public Health Minimum Price for Alcohol Wales Act 2018 forces retailers to use a formula for working out minimum pricing.

What is a unit of alcohol?

  • A unit is 10ml of pure alcohol
  • This is equivalent to about half a pint of lower or standard-strength beer or cider
  • A single 25ml shot of sprits is about one unit
  • A small 125ml glass of wine contains about 1.5 units

Source: NHS Direct Wales

What is minimum unit pricing?

Minimum unit pricing (MUP) is a method in setting a baseline price below which no one can sell an alcoholic drink. The price is based on how much alcohol is in each drink. The minimum price that’s being set in Wales is 50p per unit of alcohol. Whether the drink is beer, cider, wine, spirits or any other kind of alcoholic drink; its minimum price will depend on how much alcohol it contains. For example:

  • A standard-strength pint of beer or cider contains around 2.5 units of alcohol, so it can’t be sold in Wales for less than £1.25 (2.5 x 50p)
  • A bottle of wine has about 10 units of alcohol in it, so the minimum price for it is around £5 (10 x 50p)
  • A bottle of whisky or vodka contains around 26 units, and so cannot be sold for less than £13 (26 x 50p)

Why has it been introduced?

Official figures show about 500 people die in Wales each year from alcohol-related causes, with 60,000 hospital admissions related to alcohol consumption, adding up to an estimated £159m cost to the Welsh NHS r.

Dr Sarah Aitken, director of public health for Aneurin Bevan University Health Board, said the organisation had been supportive of the law change since it was first mooted.

“We see the effects of excessive alcohol consumption on people’s health every day,” she said.

 About Randox Testing Services

Randox Testing Services are a specialist in the workplace drug & alcohol testing industry. We provide testing solutions for companies who want to reduce the impact of substance misuse in their workplace. With a range of service options and expert staff on hand to provide help and training to staff, our services will help to eradicate the impacts of drugs and alcohol.

To find out more about our range of products and how our service packages can help your company, contact us today.

Email – testingservices@randox.com

Phone – +44 (0) 28 9445 1011

 

Want to know more?

Contact us or visit our website to read more.


Randox Testing Services announce attendance at HRD Summit 2020

16 January 2020

Randox Testing Services to attend HRD Summit 2020

 

RTS are pleased to announce we will be attending the HRD Summit 2020. The two-day event is taking place on 4-5 February at the ICC, Birmingham.

The HRD Summit plays host to the most senior HR and business leaders on the globe. The 2020 Summit will welcome over 1,500 attendees, over 150 speakers across 8 content streams, over 80 Exhibitors, over 250 Match Meetings and 11+ hours of networking spread across 2 days.

For RTS it will be the first time attending the event and UK Sales Manager Michelle Fenn is anticipating a busy and productive two days. She said,

“RTS are delighted to be attending the HRD Summit in Birmingham. It is an event that we have identified that would be ideally suited to promote the message of safer workplaces through minimising the impacts of drug & alcohol misuse. In workplaces, employers are becoming more mindful and aligned to their well-being of their employees. One part of this is ensuring a health and safety policy is in place.

A key role within this is ensuring an accurate and concise drug and alcohol policy that is effectively communicated to all employees. RTS are proud of the assistance we provide in helping companies to reduce the impact of substance misuse, so we look forward to engaging with the companies and delegates who will be attending the HRD Summit over the two days.”

As well as exhibiting in the dedicated Partner Zone at the event where delegates can engage with us directly and find out more about our services relating to drug & alcohol testing, we will also be taking part in one of the roundtable discussions that will be happening during the event, so keep an eye on our website and social media in the run up to the event for more information!

About Randox Testing Services

Randox Testing Services is a specialist in the drug & alcohol testing industry. We aim to educate and inform companies about the dangers of drug and alcohol misuse in the workplace, and the impact it can have on an organisation.

If you are attending HRD Summit and would like to speak with us about drug & alcohol testing, visit us in the Partner Zone where one of our colleagues will be happy to speak with you.

Alternatively, if you would like to know more about workplace drug & alcohol testing and how we can help your business, contact us using any of the below details.

Email: testingservices@randox.com

Phone: 028 9445 1011

 

Want to know more?

Contact us or visit our website to read more.


New report highlights scale and causes of prescription drug dependence in UK

10 December 2019

New report highlights scale and causes of prescription drug dependence in UK

 

A new report has highlighted the scale and causes of prescription drug dependence in the UK. In 2017, the minister for public health and primary care commissioned Public Health England (PHE) to identify the scale, distribution and causes of prescription drug dependence, and what might be done to address it.

The review covered adults (aged 18 and over) and 5 classes of medicines:

  • benzodiazepines (mostly prescribed for anxiety)
  • z-drugs (sleeping tablets with effects similar to benzodiazepines)
  • gabapentin and pregabalin (together called gabapentinoids and used to treat epilepsy, neuropathic pain and, in the case of pregabalin, anxiety)
  • opioids for chronic non-cancer pain
  • antidepressants

PHE’s analysis shows that, in 2017 to 2018, 11.5 million adults in England (26% of the adult population) received, and had dispensed, one or more prescriptions for any of the medicines within the scope of the review. The totals for each medicine were:

  • z-drugs – 1.0 million (2%)
  • benzodiazepines – 4 million (3%)
  • gabapentinoids – 5 million (3%)
  • antidepressants – 3 million people (17% of the adult population)
  • opioid pain medicines – 6 million (13%)

Trends

Between 2015 to 2016 and 2017 to 2018 the rate of prescribing for antidepressants increased from 15.8% of the adult population to 16.6% and for gabapentinoids from 2.9% to 3.3%. There was a small decrease in prescribing rates for the other 3 medicine classes. Rates of prescribing were higher for women (1.5 times those of men), and the rates generally increased with age. After a long increasing trend, the annual number of prescriptions for opioid pain medicines has slightly decreased since 2016. There is a continuing longer-term fall in prescription numbers for benzodiazepines. A longer-term increase in annual prescription numbers for z-drugs started to reverse in 2014.

Officials said long-term use on such a scale could not be justified and was a sign of patients dependence.

PHE medical director Prof Paul Cosford said he was worried.

“These medicines have many vital clinical uses and can make a big difference to people’s quality of life.”

But he added there were too many cases where patients were using them for longer than “clinically” appropriate – where the drugs would have simply stopped working effectively or where the risks could outweigh the benefits.

Conclusions

One in 4 adults in England were prescribed benzodiazepines, z-drugs, gabapentinoids, opioids for chronic non-cancer pain, or antidepressants. Prescriptions for antidepressants and gabapentinoids are increasing, but prescriptions for opioid pain medicines are decreasing. Prescriptions for benzodiazepines continue to fall, and those for z-drugs have more recently started to fall.

Peter Burkinshaw at PHE, one of the authors said: “The long-term prescribing of opioid pain medicines and benzodiazepines is not supported by guidelines and is not effective.”

Fellow author Rosanna O’Connor, said: “We know that GPs in some of the more deprived areas are under great pressure but, as this review highlights, more needs to be done to educate and support patients, as well as looking closely at prescribing practice and what alternative treatments are available locally.

References

Dependence and withdrawal associated with some prescribed medicines (PHE)

https://www.theguardian.com/uk-news/2019/sep/10/addictive-medication-nhs-opioid-crisis-government-study-england

Randox Testing Services

At Randox Testing Services we are at the forefront of alcohol and drug testing. We aim to spread the message of alcohol and drug misuse and the effects substance abuse can have on individuals and businesses. Prescription & OTC medication if taken incorrectly can have a devastating impact. It’s important to communicate with employers if you are taking prescription medication for any reason. If your organisation undertakes workplace testing, our chain of custody process provides clarity on the steps needed to ensure confidentiality is maintained.

For more information on drug & alcohol testing, including the wide range of substances we can test for, please visit www.randoxtestingservices.com or email testingservices@randox.com

 

Want to know more?

Contact us or visit our website to read more.


RIQAS Point of Care EQA

RIQAS Point of Care EQA Logo

Randox International Quality Assessment Scheme – Point of Care EQA

Register     /     Login

Designed to improve the quality of Point of Care Testing (POCT) in locations such as pharmacies, GP surgeries, hospital out patient departments, sports clinics, supermarkets, diagnostic/treatment and walk-in centres, RIQAS Point of Care EQA provides independent evidence of the accuracy and reliability of test results. Randox International Quality Assessment Scheme (RIQAS) is the world’s largest EQA scheme with over 47,000 participants in more than 139 countries.

Why RIQAS Point of Care?

About RIQAS Point of Care

  • How it Works

    On a monthly basis we will distribute an identical sample of blood to all participating sites.  Each participating site will test the sample in the same way they would test a real patient sample, then return their test results to RIQAS within a set time. The scheme is unique in distributing whole blood samples rather than serum based samples, this ensures that samples act identically to real patient samples at the point of care.

    An electronic report is then sent to participants, comparing their results with other participants using the same analyser.  Satisfactory and unsatisfactory performance is represented using a traffic light system, allowing instant identification of any issues. A more detailed breakdown of performance may be obtained if further information is required. With time, an overall picture will emerge showing whether results are consistently accurate and reliable or whether there may be an underlying analyser and/or operator issue.

    RIQAS Point of Care - How it works
  • Tests and Analysers



    Test Role Frequency
    HbA1c • Diagnosing diabetes mellitus
    • Monitoring treatment
    • Encouraging self-management
    Monthly
    Total Cholesterol & HDL Cholesterol • Risk factors for heart disease
    • Monitoring lipid lowering therapy
    Monthly
    C-Reactive Protein (CRP) • Early detection of infectious disease
    • Identifying need for antibiotic treatment
    Monthly
    Glucose • Diagnose and monitor diabetes
    • Monitor for the presence of hypoglycaemia
    (low blood glucose) and hyperglycaemia (high blood glucose)
    Monthly, Bi-monthly and Quarterly
    International Normalised Ratio (INR) • Used to measure the effect of anticoagulant
    drugs such as warfarin
    • Help diagnose a bleeding disorder; to help
    estimate the severity of liver disease
    Monthly
    Ketones • To determine whether excessive ketones are
    present in the blood, to detect diabetic
    ketoacidosis (DKA)
    Monthly, Bi-monthly and Quarterly
    Note – The RIQAS Point of Care range is constantly expanding to include new tests and analysers. Please contact us if your desired analyser or test is not currently displayed.
  • Ordering Information

    Panel Catalogue Number
    Lipids RQ9181/A
    Lipids + 1 panel RQ9181/B
    Lipids + 2 panels RQ9181/C
    Additional Sample RQ9181/D
  • What Participants Say

    Our unrivalled commitment to quality and service ensures high levels of customer satisfaction, this is evident from the responses to our latest customer satisfaction survey:

    “All in all a quick and efficient service”
    “Good online system”
    “Very helpful team”
    “Excellent training”
    “They are an experienced team”
    “Very satisfied with the service that we receive”
    “Very good value for money”
    “The website is great”
  • Distribution Dates

    Distribution Month Sample Distributed Result Submission Deadline
    January 2022 10th January 19th January
    February 2022 7th February 16th February
    March 2022 7th March 16th March
    April 2022 4th April 13th April
    May 2022 3rd May 11th May
    June 2022 6th June 15th June
    July 2022 4th July 13th July
    August 2022 1st August 10th August
    September 2022 5th September 14th September
    October 2022 3rd October 12th October
    November 2022 7th November 16th November
    December 2022 5th December 14th December
  • Importance of Quality Assurance

    Quality assurance is an essential aspect of any clinical/diagnostic testing service and is aimed at ensuring the accuracy and reliability of patients’ results. The right result allows the right clinical advice to be offered in a timely manner. Quality assurance operates at two levels:

    Internal Quality Control

    Internal Quality Control includes operator training/ competency assessment, analyser/ test system maintenance, and adherence to policies/ processes. Whilst some point of care analysers include inbuilt quality checks, cross-check analysis against samples with known levels provides immediate assurance and evidence that a patient’s result is safe to report.

    External Quality Assessment

    External Quality Assessment involves analysis of samples with unknown levels that have been distributed by an external organisation. Participants are informed how their results compare with other participants, hence providing independent evidence of performance. Increasingly, participation in an external quality assessment scheme is becoming a mandatory requirement where health and healthcare services are being provided.

    EQA provides assurance to both staff and customers that testing provides accurate and reliable results.

    Want to know more?

    Visit our Importance of EQA page to learn more.

Want to know more?

Contact us or download the RIQAS Point of Care catalogue to learn more.

Continue Reading

Frequently Asked Questions

RIQAS

Contact Us


Practical steps for dealing with substance misuse in the workplace

11 November 2019

Practical steps for dealing with substance misuse in the workplace

 

What is substance misuse?

Substance misuse (or abuse) is defined as the sustained use of any mind-altering substance. This includes legal substances like solvents and alcohol as well as illegal drugs. Through this continued use the user’s physical and mental health are severely affected. The misuse of substances in the workplace can cause issues such as increased absenteeism, low productivity and create an unsafe working environment.

It is estimated that between 3% and 5% of all work absences are due to alcohol abuse and that 1 in 30 employees has had drugs in their system at one time in the workplace. All employers have a legal responsibility to ensure the health, safety and welfare of their employees and so statistics like this cannot be ignored.

What can employers do?

As an employer, it is important that measures are taken to protect all employees and the company from potential dangers. To do this, employers should:

Introduce a comprehensive drug and alcohol policy. This lets all stakeholders know exactly where the company stands on substance misuse and shows that you are being proactive in your approach.

Conduct drug and alcohol testing. Utilising random and/or with cause testing can help quickly identify any substance misuse issues. Consider including a contractual obligation for employees to co-operate with this.

Train staff to identify the signs of substance misuse. Make everyone aware of the issue and give them the ability to look for the key signs. This can only help increase safety.

Keep up-to-date with the latest legislation. The laws on substance misuse can change quite quickly, especially as new substances like legal highs are identified and re-classified. Ensure you are aware of the latest changes.

Support employees. Addiction or frequent misuse of substances should be treated the same way as other health issues. Offer support to your employees and help them make a quick return to work.

The above steps can help better manage the issue of substance misuse in the workplace. Effectively communicating the company’s stance on this issue to employees brings clarity and lets everyone know where they stand.

Randox Testing Services

At Randox Testing Services we offer comprehensive drug and alcohol testing solutions for workplaces. We incorporate cutting-edge screening methods to provide an outstanding testing service and are well-positioned to provide consultancy and support to help you put an effective workplace drug and alcohol testing policy in place.

For more information contact us at testingservices@randox.com.

Want to know more?

Contact us or visit our website to read more.


RTS | Which company testing is right for me?

04 October 2019

Which company testing method is right for me?

 

Implementation of an effective substance misuse policy establishes employer rights to conduct workplace drug and alcohol testing if required. In addition, it ensures adherence to the duty of care of an employer to protect their workforce and keep employees safe. There are a range of approaches available to complement your policy to ensure a safer working environment. In this blog we take a look at two common types of testing; random testing and with-cause testing.

Random Testing

With knowledge that a test could be conducted with anyone at any time, random testing is the most effective deterrent of drug abuse or alcohol misuse among employees. Ensuring the integrity of staff across all levels, random testing can be conducted with employees at any level, from temporary employees to managers and directors.

Process

The process includes ensuring a clear workplace drug and alcohol testing policy is in place. Employees should also be made aware that random drug and alcohol testing is carried out; this can take the form of a clear statement in an employee’s contract outlining that random testing can be conducted with little to no notice. Notification of this conforms to legislation whilst respecting employee rights.

Secondly, we will work with you to determine the percentage of your workforce you would like to test, and how often you would like testing to be carried out. Whilst we recommend random drug and alcohol testing should be performed at least quarterly, the decision is yours. To avoid employee discrimination and to ensure testing is random, we use our random selection technology to eliminate bias and provide accurate random selections.

Finally, we will arrive to your workplace unannounced to carry out sample collections from the random selection of employees.

Key Benefits

By implementing a random drug testing may help employers by:

  • Deterring current employees from engaging in drug use
  • Preventing the need for substance abuse recovery programs
  • Employees are less likely to tactfully try to disguise results, or alter their habits, as they will be given little to no notice that a test is going to be conducted
  • Improving attendance and employee productivity
  • Providing a safer workplace with reduced accidents

With-Cause Testing

Under the Misuse of Drugs Act (1971), if an employer suspects an employee is under the influence of drugs or alcohol, they are legally required to take appropriate action to protect the safety of the employee concerned, other members of staff and the public.

Process

The nature of with-cause testing means that testing can be required ‘on-the-spot’. At Randox Testing Services, we offer a 24-hour call-out service which guarantees an experienced collection officer will arrive to your company within a maximum of 2 hours to perform a sample collection. This service is available 24/7, 365 days a year and complies fully with chain of custody procedures.

Benefits

  • Legal compliance with correct measurements being taken if an employee is suspected of being under the influence of drugs or alcohol
  • Can deter employee misuse of drugs or alcohol due to a workplace testing policy being in place
  • Cost savings because of increased productivity with issues being discovered and rectified early

How Randox Testing Services can help

At Randox Testing Services we possess a wealth of experience and knowledge that enables us to offer holistic packages to meet the needs of the customer, regardless of their location or industry. This knowledge comes from over 35 years of testing experience in the diagnostics industry and through our involvement with bodies that help shape testing legislation.

For more information about our range of drug & alcohol testing products, our expertise in this industry and our array of support services, visit www.randoxtestingservices.com.

If you would like to speak with one of our experts, use any of the following methods:

Email: testingservices@randox.com

Phone: +44 (0) 28 9445 1011

Want to know more?

Contact us or visit our website to read more.


Addressing Drugs and Alcohol in the Workplace

05 September 2019

Workplace Drug and Alcohol Testing

Addressing Drugs and Alcohol in the Workplace

Within any business, companies seek to outline clear methods in which employees should act and behave whilst carrying out their roles. These rules are outlined in company workplace policies. Every business – no matter which industry it operates in – should have well-documented and comprehensive workplace policies and procedures in place.

According to the Employment Law Handbook, a workplace policy is a set of rules and principles that aims to provide guidance to managers and workers in how to behave in the workplace. They can be in place for numerous different issues – bullying, harassment, internet use, health and safety are just a few that can be implemented.

Health and Safety

As mentioned above, health and safety is an important aspect of any workplace policy. The health and well-being of the working community is of utmost importance for sustainable development. Specifically, a drug and alcohol policy is a key part of the overall health and safety policy within a company. Alcohol and drugs through their effects on health, safety, work performance and absenteeism can jeopardise productivity, deny businesses the leading edge and curtail competitiveness. Effectively implemented drug and alcohol policies will help employers in the legal duty to protect the health, safety and welfare of employees.

The need for a Drug and Alcohol Policy

Drugs and alcohol misuse can have dangerous consequences within the workplace. All organisations can benefit from an agreed policy that applies to all staff. There are wide range of statistics available to highlight the worrying impact that drugs and alcohol can have on individuals. In 2016, it was estimated that £7 billion was lost in productivity through unemployment and sickness. Furthermore, 10.8 million adults in England are drinking at levels that pose some risk to their health. A survey carried out by UK based Health and Safety Consultants Protecting.co.uk showed that; from 2,600 workers in office, factory, retail and the public sector, 85% admit to being drunk at work in the last year; not including the Christmas party. 28% of those surveyed admitted using drugs at work, including NPS (formerly legal highs) cannabis and other illegal substances.

From a legal point of view, employers have a duty of care under the Health and Safety at Work Act 1974 to ensure, as far as is reasonably practicable, the health, safety and welfare at work of employees. Also, under the Management of Health and Safety at Work Regulations 1999, to assess the risks to the health and safety of employees. If an employer knowingly allows an employee under the influence of drug misuse to continue working and his/her behaviour places the employee or others at risk, they may face prosecution.

Advantages of having policies in place

Having well-developed policies and procedures can provide a range of benefits to an organisation. An effectively implemented drug and alcohol policy will ensure a clear understanding within the workplace of the rules relating to drugs and alcohol. It will also provide a greater awareness in workplaces of the effects of drugs and alcohol an consequently early recognition. Furthermore, it ensures that the necessary structures and procedures are in place should a problem arise. An up to date policy will also provide assurance that key staff have been trained to understand the issues involved and have the necessary skills to deal with any problems should they arise.

How can Randox Testing Services help?

At Randox Testing Services we offer a comprehensive consultancy service to help employers create an effective substance misuse policy. By providing this service we offer practical advice, guidance and support in composing a substance misuse policy.

Our confidential policy review service provides assistance to employers with an existing substance misuse policy. With this service, we help to modify existing documents to ensure it is legally viable and can withstand challenge in court.

For more information on our comprehensive consultancy service, visit our website: www.randoxtestingservices.com or contact us by emailing testingservices@randox.com.

To read more about workplace polices and their importance within an organisation, click here.

 

Want to know more?

Contact us or visit our website to read more.


Flexible Drug and Alcohol Testing Methods

06 August 2019

Flexible Drug and Alcohol Testing Methods

At Randox Testing Services our complete testing solutions include flexible drug and alcohol testing methods that can be tailored to meet our customer needs. In all aspects of testing we ensure the accuracy and reliability of results and utilise strict chain of custody procedures across all our testing methods.

To guarantee the most effective form of testing our dedicated Account Managers make informed recommendations to our customers on what type of testing best suits their business needs. The different methods are outlined below along with the sample types that can be tested:

Drug and Alcohol Testing Methods

  • Abstinence Monitoring

Conducted as a follow up on a confirmed positive drug or alcohol test. If an employer provides support to an employee who has had a confirmed positive drug or alcohol test, this type of testing may be used to help with rehabilitation.

  • Post-Incident

Used to determine if drugs or alcohol may have contributed to an accident/incident in the workplace. This type of testing can be an effective tool in accident investigations and it is our recommendation that should an incident occur, all employees involved should be tested.

  • Pre-Employment

This is the most popular type of workplace testing especially in industries which have safety critical roles. This type of testing is an essential part of a company’s recruitment process and clearly states the company’s position on drug and alcohol misuse for any potential employee.

  • Random

A popular type of testing within workplaces as it acts as a deterrent to drug and alcohol abuse. A company’s drug and alcohol testing policy should clearly outline that they carry out random workplace testing ensuring employees do not know when the event is planned.

  • With-Cause

Performed when a company is suspicious that an employee may be currently under the influence of alcohol or misusing drugs. This suspicion is normally raised if an employee is acting out of character and there has been observed different behaviours.

Sample Types

  • Urine (Alcohol and Drugs)

The most common sample type for drug testing and offers a longer detection window than oral fluid for drugs.

  • Oral Fluid (Drugs only)

Oral fluid testing analyses a saliva sample for parent drugs and their metabolites, providing analysis of short-term drug abuse.

  • Hair (Alcohol and Drugs)

A hair drugs test offers a longer window of detection than alternative testing and can provide a detailed view or overall picture of drug use. Detection window is based on hair length with 1cm of head equating to approximately 1 month of detection.

  • Breath (Alcohol only)

Breath can be tested for alcohol using hand-held devices which provide immediate results. These devices can gauge blood alcohol content (BAC) by measuring deep lung air.

About Randox Testing Services

Randox Testing Services is a market leader in the drug and alcohol testing industry. Our expertise is relied upon by a range of leading safety-critical companies across the world.

We pride ourselves on helping our customers improve the health and safety of their working environment through helping them implement a comprehensive substance misuse policy. Our expertise within this industry allows us to craft customised packages to meet the testing needs of any workplace. Our drug and alcohol testing methods are flexible to adapt to any changes and our testing processes are accurate, to guarantee reliable results.

Contact us today be at testingservices@randox.com or call 028 9445 1011 to speak to one of our experts.

Want to know more?

Contact us or visit our website to read more.


Q&A with Randox Testing Services: All Things Workplace Drug & Alcohol Testing

At Randox Testing Services, we are always trying to think of new ways to get the message across about the positive impact workplace drug & alcohol testing can have on an organisation. So, we decided to speak with one of our colleagues; Simon Tibbo, who is regularly engaging with companies about how to be proactive in minimising the risks of substance misuse.

Read below to find out what he had to say.

From your experience and knowledge, what industries are currently implementing testing programmes?

Apart from the finance industry, I’ve personally seen testing programmes within almost all business sectors, from the obvious, safety critical industries, Rail Track, Maritime, Construction, Logistics, all the way through to manufacturing firms, retail outlets, and even predominantly clerical companies. If a company has a workplace substance misuse policy and are looking to satisfactorily enforce the terms within, they will be engaged with a service provider, such as Randox, to properly support the policy.

 

What are, in your opinion, the barriers that companies face when trying to implement working drug & alcohol testing?

The introduction of a substance misuse policy to an already existing ‘company handbook’ can be a challenge, especially if the work-force has been established for some time. People don’t tend to like change, especially within the workplace. Unions can sometimes be unwelcoming to the idea of random testing and will often look to restrict the scope of testing or the policy itself. I’d say that each industry/company will likely meet its own barriers whilst developing and implementing a policy, and some may well be unique to the individual circumstances. Often, customers may implement an amnesty period prior to the commencement of a drug testing programme. This gives employees the opportunity to come forward and declare if they have a substance misuse issue which they can address together with their employer without sanctions.

 

Why has there been a delay in some companies developing workplace policies that directly relate to substance misuse?

There could be many reasons as to why a company hasn’t implemented a policy, but I’d expect somewhere near the top of that list would be either the assumption there isn’t a substance misuse issue within the business/industry, the worry that a substance misuse issue within the business/industry is highlighted by the introduction of a policy, and therefore creating more problems than its seen to be solving, or even that a company is simply unaware the solution is available and beneficial.

 

How important within a policy is it that a company clearly outlines what is expected of an employee, and the consequences of substance misuse?

Very! A policy needs to be clear and concise in its structure and procedures. If you aren’t explaining the terms or the consequences you could potentially end up with a problematic HR process and unresolvable tribunal cases. If an employee has sight of a straightforward policy they will know what to expect if the terms are breached, not to mention enforcing it should be equally as straightforward. It is also important to state why the policy is in place – i.e. to protect the workforce, the public and the company reputation.

 

Is it important to state cut-offs in substance misuse policies?

For alcohol, yes, most certainly. For drugs, not so much. An alcohol test with a home office approved breathalyser will provide an evidential result, which can be directly related to a ‘site cut-off’ (in the same manner as the existence of a road legal limit). Workplace drug testing should adhere to specific guidelines set-out by the EWDTS (European Workplace Drug Testing Society) in not just it’s procedures, but also its expected substance cut-offs. The cut-offs differ between substances so it’s not quite as straightforward. My suggestion would always be, if you feel it necessary to include drug cut-off information, refer to the EWDTS guidelines, they’re available to download on the EWDTS website if anyone needs sight, but ensure your provider is working to them and don’t go into full details, it’ll serve only to add unnecessary bulk to what should ideally be a streamlined policy.

 

How effective has workplace testing been in helping companies reduce the risk of drug & alcohol use?

From personal experience I can tell you, I’ve seen companies implement a policy/testing practice due to an awareness of substance misuse, only to reduce the volume of testing over time as the approach has proved successful in reducing or eradicating the specific problem. I’d say that’s a testament to implementing a random testing practice, it sends a sensible message in a fair and balanced manner, which ultimately gets results. If it’s done right, it’s going to be beneficial, even if it’s not particularly well received at its inception. Other examples where testing volume has been scaled back have led to an increase in the rates of positives demonstrating that an active testing programme is a deterrent to substance misuse.

 

Going forward, what industries do you see adopting a more proactive approach in use of substance misuse testing?

Likely most industries, every company has a duty of care to staff, contractors, visitors and/or the public. There will always be industries that don’t agree, don’t want to uncover issues or don’t believe they exist, but it’s the people that matter and the more that’s done to promote safety, welfare and overall good practice, the more industries will settle to the idea.

 

About Randox Testing Services

Randox Testing Services offer a wide range of products and services for the testing of illicit substances. We can craft customised packages to suit the needs of our customers, no matter what the industry.

Our expertise and experience working within this industry allow us to provide a range of testing solutions that will impact the risk of substance use in the workplace. With an extensive collection network and quality products, we can meet the needs of your business.

To find out more, contact us:

Email: testingservices@randox.com

Phone: +44 (0) 28 9442 2413

 

 

 

 

 

 

 

 

 

 

 

 


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Future Diagnostics
×
Make an Enquiry - RX series (Product)
×
Make an Enquiry - Quality Control
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - RIQAS
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents